Author:
Cruz Carmela Rieline V.,Ferrer Jose Lorenzo M.,Garcia Reynaldo L.
Abstract
AbstractLung cancer is the leading cause of cancer deaths worldwide, with smoking as its primary predisposing factor. Although carcinogens in cigarettes are known to cause oncogenic DNA alterations, analyses of patient cohorts revealed heterogeneous genetic aberrations with no clear driver mutations. The contribution of noncoding RNAs (ncRNAs) in the pathogenesis of lung cancer has since been demonstrated. Their dysregulation has been linked to cancer initiation and progression. A novel long noncoding RNA (lncRNA) called smoke and cancer-associated lncRNA 1 (SCAL1) was recently found upregulated in smoke-exposed adenocarcinomic alveolar epithelial cells. The present study characterized the phenotypic consequences of SCAL1 overexpression and knockdown using A549 cells as model system, with or without prior exposure to cigarette smoke extract (CSE). Increase in SCAL1 levels either by CSE treatment or SCAL1 overexpression led to increased cell migration, extensive cytoskeletal remodeling, and resistance to apoptosis. Further, SCAL1 levels were negatively correlated with intracellular levels of reactive oxygen species (ROS). In contrast, SCAL1 knockdown showed converse results for these assays. These results confirm the oncogenic function of SCAL1 and its role as a CSE-activated lncRNA that mediates ROS detoxification in A549 cells, thereby allowing them to develop resistance to and survive smoke-induced toxicity.
Funder
National Institute of Molecular Biology and Biotechnology, University of the Philippines Diliman
Publisher
Springer Science and Business Media LLC
Reference50 articles.
1. Karlsson, A. et al. Genomic and transcriptional alterations in lung adenocarcinoma in relation to smoking history. Clin. Cancer Res. 20, 4912–4924 (2014).
2. Islami, F., Torre, L. A. & Jemal, A. Global trends of lung cancer mortality and smoking prevalence. Transl. Lung Cancer Res. 4, 327–338 (2015).
3. Hecht, S. S. Cigarette smoking and lung cancer: Chemical mechanisms and approaches to prevention. Lancet Oncol. 3, 461–469 (2002).
4. Luo, J. et al. Long non-coding RNA CARLo-5 is a negative prognostic factor and exhibits tumor pro-oncogenic activity in non-small cell lung cancer. Tumor Biol. 35, 11541–11549 (2014).
5. Guo, L. et al. Long non-coding RNA DANCR promotes the progression of non-small-cell lung cancer by inhibiting p21 expression. OTT 12, 135–146 (2018).
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献